BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26771692)

  • 1. Different-Sized Gold Nanoparticle Activator/Antigen Increases Dendritic Cells Accumulation in Liver-Draining Lymph Nodes and CD8+ T Cell Responses.
    Zhou Q; Zhang Y; Du J; Li Y; Zhou Y; Fu Q; Zhang J; Wang X; Zhan L
    ACS Nano; 2016 Feb; 10(2):2678-92. PubMed ID: 26771692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses.
    Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S
    J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy.
    Xiang J; Xu L; Gong H; Zhu W; Wang C; Xu J; Feng L; Cheng L; Peng R; Liu Z
    ACS Nano; 2015 Jun; 9(6):6401-11. PubMed ID: 26028363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response.
    Zhang P; Chiu YC; Tostanoski LH; Jewell CM
    ACS Nano; 2015 Jun; 9(6):6465-77. PubMed ID: 26035231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of nanoparticles towards targeting antigen-presenting cells and improved T cell priming.
    Zupančič E; Curato C; Paisana M; Rodrigues C; Porat Z; Viana AS; Afonso CAM; Pinto J; Gaspar R; Moreira JN; Satchi-Fainaro R; Jung S; Florindo HF
    J Control Release; 2017 Jul; 258():182-195. PubMed ID: 28511928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
    Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
    J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active dissemination of cellular antigens by DCs facilitates CD8
    Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
    Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
    Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
    J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.
    Han JA; Kang YJ; Shin C; Ra JS; Shin HH; Hong SY; Do Y; Kang S
    Nanomedicine; 2014 Apr; 10(3):561-9. PubMed ID: 24262997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
    Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
    Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.
    Jin H; Qian Y; Dai Y; Qiao S; Huang C; Lu L; Luo Q; Chen J; Zhang Z
    Theranostics; 2016; 6(11):2000-2014. PubMed ID: 27698936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
    Robson NC; Donachie AM; Mowat AM
    Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CCR4 antagonist enhances DC activation and homing to the regional lymph node and shows potent vaccine adjuvant activity through the inhibition of regulatory T-cell recruitment.
    Yamamoto S; Matsuo K; Nagakubo D; Higashiyama S; Nishiwaki K; Oiso N; Kawada A; Yoshie O; Nakayama T
    J Pharmacol Sci; 2018 Mar; 136(3):165-171. PubMed ID: 29519579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivered antigen peptides to resident CD8α
    Wang L; Wang Z; Qin Y; Liang W
    Eur J Pharm Biopharm; 2020 Feb; 147():76-86. PubMed ID: 31887349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.